Lederle vaccine pricing policy
Executive Summary
Company pledges no price increases for vaccine products in 1993 and commits to keeping 1994 price increase for individual vaccine products under the Consumer Price Index. The company says March 24 that annual price increases for all Lederle pharmaceutical products have averaged 1.5% over the last six years compared to the 4.2% annual inflation rate. The private sector price of the polio vaccine Orimmune increased from $9.37 to $9.89 between 1991 and 1992, while the government price increased by 9[cents] to $1.55. Meanwhile the price of the firm's DTP vaccine Tri-Immunol stayed the same for the private sector and decreased from $1.30 to 64[cents] to the government.